National Health Act 1953 Declaration under subsection 85(2AA) (No. PB 3 of 1991) (Cth)

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUBSECTION 85(2AA)

No. PB3 of 1991

I, MARGARET NONA FORD, Principal Advisor, Health Care Access Division, Department of Community Services and Health and Delegate of the Minister of State for Community Services and Health, having in accordance with subsection 85(2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85(2AA) of the National Health Act 1953, hereby make the following Declaration:

1. This Declaration shall come into operation on 1 April 1991.

2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

Chlormethiazole

Mefruside

Polymyxin B Sulphate with Neomycin Sulphate and Hydrocortisone

Acriflavine B.P.C. 1963

Adrenaline B.P.

Atropine Sulphate B.P.

Bentonite B.P.

Chlorhexidine Gluconate Solution B.P.

Chlorocresol B.P.

Ferrous Sulphate, Dried B.P.

Hydrochloric Acid B.P.

Hydrous Ointment B.P.

Hyoscyamus Liquid Extract B.P.C. 1973

Lemon Spirit B.P.

Lignocaine Hydrochloride B.P.

Oily Cream A.P.F.

Phenobarbitone B.P.

Phenoxyethanol B.P.

Pilocarpine Hydrochloride B.P.

Pilocarpine Nitrate B.P.

Sodium Acid Phosphate B.P.

Sodium Phosphate B.P.

Theophylline B.P.

Titanium Dioxide B.P.

Dated this twenty-second day of March 1991.

MARGARET FORD

Principal Advisor

Health Care Access Division

Department of Community Services and Health

Delegate of the Minister of State for Community Services and Health